Clinical trial
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
NCT06341452 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 16, 2025
- Completion date
- December 31, 2026
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease